UNSPSC 51472304: Meralein sodium

This classification denotes an anti-infective agent with the molecular formula C19H8HgI2O6S.Na.HO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 77CVD9244H, chemically known as spiro(3h-2,1-benzoxathiole-3,9-(9h)xanthene)-3,6-diol, 2,7-diiodo-, 1,1-dioxide, mercury complex but generally known as meralein sodium, which bears US NIH Compound Identifier 20408. European Medicines Agency schedules Meralein sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08768MIG.

UNSPSC 51472304 Meralein sodium is a Commodity code that captures pharmaceutical and chemical supply procurements by state and local health systems, correctional facilities, and county public-safety agencies. The recent opportunities block shows little activity explicitly tagged to meralein sodium itself; instead, the code appears primarily in broader pharmaceutical and janitorial supply solicitations where it may be nested as one line item among many consumables. State and local governments buy meralein sodium as part of larger standing contracts for generic pharmaceuticals, over-the-counter products, and operational supplies supporting emergency services, corrections, and public health. Issuing bodies include county boards of commissioners, state departments of administration, and multistate cooperative purchasing alliances administering centralized contracts for health-system and public-safety networks.

Recent activity shows two representative solicitations: Hillsborough County Board of County Commissioners issued ITB 26-00319 on July 7, 2026, for consumable janitorial and operational supplies to support 47 fire stations across Hillsborough County, Florida, with a one-year estimated value of $765,679.84 and response deadline of July 24, 2026; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP on January 20, 2026, for generic multi-source pharmaceuticals and OTC products serving participating state and local facilities across Minnesota and Oregon, with proposals due March 26, 2026, and awarded contracts effective July 1, 2026. The geographic spread centers on Florida and the Upper Midwest. Meralein sodium procurement under this code remains limited in visibility within posted state and local solicitations; most demand appears absorbed into larger pharmaceutical or operational-supply frameworks rather than solicited as a standalone line item.